He helped Gilead score billions from HIV, hepatitis C drugs — now he's building a cancer fighter
May 23, 2018 at 06:00 AM EDT
During his tenure at Gilead, Norbert Bischofberger saw employment go from 25 or so to 10,000 as the company cranked up life-changing drugs fighting HIV and hepatitis C. Now he wants to build again, and Gilead Chairman John Martin is coming along, too.
